There is one clinical trial.
PATIENTS WHO ARE ADMITTED TO HOSPITALIZATION IN HCOR AND WHO HAVE THE CONFIRMED DIAGNOSIS OF CORONA VIRUS, WILL BE ASKED TO CONSENT TO PARTICIPATE IN THIS STUDY THAT INTENDS TO STUDY THE EFFECTIVENESS OF THE REMOTE INTERCESSION PRAYER IN COMBATING THIS DISEASE.
Description: WE WILL EVALUATE DEATHS OR HOSPITAL DISCHARGEMeasure: DEATH OR RECOVERY Time: 60 DAYS
Description: NEED FOR MECHANICAL VENTILATIONMeasure: NEED FOR MECHANICAL VENTILATION Time: 60 DAYS
Description: TIME OF REMAINED INTUBATEDMeasure: TIME OF REMAINED INTUBATED Time: 60 DAYS
Description: LENGTH OF STAY IN ICUMeasure: LENGTH OF STAY IN ICU Time: 60 DAYS
Description: TIME OF STAY HOSPITALIZEDMeasure: TIME OF STAY HOSPITALIZED Time: 60 DAYS
Description: Occurrence of clinical complications that were not included before diagnostic confirmation and that may be related to covid infection.Measure: Occurrence of clinical complications. Time: 60 DAYS
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports